FALCON POINT CAPITAL, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.97 and the average weighting 0.2%.

Quarter-by-quarter ownership
FALCON POINT CAPITAL, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$2,698,000
-71.5%
81,223
-56.9%
1.61%
-20.8%
Q3 2018$9,483,000
+110.3%
188,341
+149.9%
2.04%
+129.9%
Q2 2018$4,510,000
-63.5%
75,352
-72.0%
0.89%
-64.1%
Q1 2018$12,343,000
-2.2%
269,504
-14.9%
2.47%
+16.0%
Q4 2017$12,621,000
-9.6%
316,706
-5.6%
2.13%
+4.9%
Q3 2017$13,963,000
+39.2%
335,659
+44.3%
2.03%
+49.9%
Q2 2017$10,028,000
-34.3%
232,664
-52.3%
1.35%
-33.5%
Q1 2017$15,266,000
+19.1%
487,717
-3.9%
2.04%
+18.6%
Q4 2016$12,815,000
+42.6%
507,507
+11.8%
1.72%
+24.9%
Q3 2016$8,989,000
+53.2%
454,002
+57.6%
1.38%
+35.7%
Q2 2016$5,868,000
-5.8%
288,092
-29.5%
1.01%
-5.8%
Q1 2016$6,229,000
+52.1%
408,479
+34.1%
1.08%
+21.6%
Q4 2015$4,094,000
+159.4%
304,603
+170.9%
0.88%
+56.7%
Q3 2015$1,578,000
-13.8%
112,455
+4.3%
0.56%
-8.9%
Q2 2015$1,830,000
+567.9%
107,778
+375.3%
0.62%
+190.6%
Q1 2015$274,00022,6740.21%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders